WEDNESDAY, Sept. 5, 2018 -- The selective inhibitor of influenza cap-dependent endonuclease, baloxavir marboxil, is superior to placebo for alleviating influenza symptoms, according to a study published in the Sept. 6 issue of the New England...
Original Article: Baloxavir Superior to Placebo for Alleviating Flu Symptoms